News

Attorney's Eran Ben- Dor & Tamir Chagal from our Tel Aviv office represented Colospan as they successfully completed a $ 7.7 million financing round and reported success with clinical trials.

Attorney's Eran Ben- Dor & Tamir Chagal from our Tel Aviv office represented Colospan as they successfully completed a $ 7.7 million financing round and reported success with clinical trials.
Read more

The International team counseled Alcobra Pharma Ltd in a unique transaction, known as a Reverse IPO.

The International team  counseled Alcobra Pharma Ltd in a unique transaction, known as a Reverse IPO.
Read more

”Winning Tactics in Tenders” - a seminar held by the firm in cooperation with the ACC-Israel, led by Tomer Raif, Head of the Litigation and Tenders dept.

”Winning Tactics in Tenders” - a seminar held by the firm in cooperation with the ACC-Israel, led by Tomer Raif, Head of the Litigation and Tenders dept.
Read more

The firm has been ranked again this year among the leading firms by the Ranking BDiCode

The firm has been ranked again this year among the leading firms by the Ranking BDiCode
Read more

UK office wins second year ”Best Trade Finance Law Firm

UK office wins second year ”Best Trade Finance Law Firm
Read more

US office Ranked in the 2017 Edition of Chambers USA

US office Ranked in the 2017 Edition of Chambers USA
Read more

Dun's 100 - 2017 edition has ranked ZAG-S&W among the leading law firms in Israel

Dun's 100 - 2017 edition has ranked ZAG-S&W among the leading law firms in Israel
Read more

US Office Ranked in the 2017 edition of The Legal 500 United States

US Office Ranked in the 2017 edition of The Legal 500 United States
Read more

The Firm continues to lead in the International rankings The Legal 500 EMEA in areas: Hi-Tech, Capital Markets,Trade and M&A

The Firm continues to lead in the International rankings The Legal 500 EMEA in areas: Hi-Tech, Capital Markets,Trade and M&A
Read more

Medigus Ltd. announced a public offering of approximately $ 7.5 million

Medigus Ltd. announced a public offering of approximately  $ 7.5 million
Read more

ZAG-SW represented BiomX in 24$ Million Initial Public Offering

ZAG-SW represented BiomX in 24$ Million Initial Public Offering
Read more